Effective January 24, 2022, the FDA updated the Emergency Use Authorization (EUA) fact sheets for two COVID-19 monoclonal antibody treatments: bamlanivimab plus etesevimab (Eli Lilly) and casirivimab plus imdevimab (Regeneron, also known as REGEN-COV). Neither of these treatments are authorized for use anywhere in the U.S. due to their ineffectiveness against the dominant Omicron variant. Sites are directed to immediately stop administering these therapeutics as they do not retain EUA.

Ph: (443) 281-9157

Fax: (410) 582-8728

801 Landmark Dr.
Glen Burnie, MD 21061
Contact Us

Mon-Fri: 8:30AM-6:30PM

Sat: 9:00AM-2:00PM
Fusion Columbia
Fusion Columbia

We set up to have this group come in and provide flu shots to our team. They were such an awesome team to work with! From the beginning they were flexible with our hectic schedules, super friendly and patients as we figured out the best and safest way to make this happen! As a school we highly recommend them, thank you Soleil!

    Your Cart
    Your cart is emptyReturn to Shop